New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)

Conflict of interest

Akira Shimada: lecture fee (Sanofi, Novo, Lilly, Terumo, Sumitomo, Abbott). Norio Abiru: lecture fee (Novo, Lilly). Haruhiko Osawa: research funding (Sysmex), scholarship donation (Daiichi-Sankyo, Novo). Tomoyasu Fukui: research funding (Cosmic). Junnosuke Miura: lecture fee (Terumo). Kazuki Yasuda: scholarship donation (Ono). Akihisa Imagawa: research funding (Parexel International, Taiho, MSD, Ono). Hiroshi Ikegami: lecture fee (Sanofi, Sumitomo, Terumo, Novo), scholarship donation (Sumitomo, Taisho, Life Scan, Novo). Other authors: nothing to declare.

留言 (0)

沒有登入
gif